描 述:MART-1 (26-35) has been shown to be better recognized by a number of polyclonal and monoclonal populations of tumor-reactive HLA-A*0201-restricted cytotoxic T lymphocytes (CTL) than MART-1 (27-35) (human).許多腫瘤反應(yīng)性HLA-A*0201限制性細(xì)胞毒性T淋巴細(xì)胞(CTL)的多克隆和單克隆群體對MART-1(26-35)的識別能力強于MART-1(27-35)(人)。